GlassScriptPhysician profile
Abhijit Desai
NPI 1376542936
$14,101.38
in general payments reported to CMS, 2019-2025
45 companies · $1,754 in 2025
The $1,754 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,750 · 2020: $1,394 · 2021: $2,896 · 2022: $2,654 · 2023: $1,526 · 2024: $1,127 · 2025: $1,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,222 · Travel and Lodging: $916 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,221.77 |
| Travel and Lodging | $915.71 |
| Education | $269.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,135.92 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,442.21 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $1,406.43 | 2019-2024 | Xarelto |
| Cvrx, INC. | $1,206.45 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $1,076.62 | 2019-2025 | Cardiomems, Esprit, Diamondback Peripheral |
| Astrazeneca Pharmaceuticals LP | $757.76 | 2019-2023 | Farxiga |
| Amgen INC. | $637.55 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $637.42 | 2020-2023 | Nexletol |
| Amarin Pharma, INC. | $527.61 | 2019-2021 | |
| Pfizer INC. | $502.77 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $453.82 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $453.22 | 2019-2025 | Watchman Access System |
| Merck Sharp & Dohme LLC | $341.01 | 2021-2023 | Verquvo |
| Novo Nordisk INC | $304.49 | 2019-2023 | Ozempic |
| Imperative Care, INC | $223.80 | 2024 | Symphony Catheter |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhijit Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.